Author

Martine Daujat‐Chavanieu

InsermORCID 0000-0001-5560-1610Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:ATAC-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Sabine Gerbal‐ChaloiniD· 2 shared Alain ChavanieuiD· 1 shared Anthony R. MartiniD· 1 shared Baptiste LegrandiD· 1 shared Basile JayiD· 1 shared Christine NeuveutiD· 1 shared Émilie Rigal· 1 shared Gabrielle Pozo· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Sabine Gerbal‐ChaloinORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintNov 10, 2025

The histone variant H2A.Z and its chaperone SRCAP are required for RNA polymerase II to access HBV chromatin

Basile Jay, Océane Lopez, Laetitia Gérossier…·Joao Diogo Dias

This study identifies H2A.Z and SRCAP as essential for HBV cccDNA transcription by promoting chromatin accessibility and RNA polymerase II recruitment.

DOI 10.1101/2025.11.10.687638

humanChIP-seq

𝕏 PostBluesky

Cancer BiologyOncogenesisPeer-reviewedAug 30, 2025

Targeting Pregnane X Receptor with a Potent Agonist-Based PROTAC to Delay Colon Cancer Relapse

Lucile Bansard, Guillaume Laconde, Vanessa Delfosse…·Jean‐Marc Pascussi

This study designs and tests a PXR agonist-based PROTAC (JMV7048) that degrades PXR in cancer cells, reducing chemoresistance and delaying colon cancer relapse.

8 citations

humanexperimental assay

𝕏 PostBluesky